Figure 2From: Efficacy, safety and pharmacokinetic of once-daily boosted saquinavir (1500/100 mg) together with 2 nucleos(t)ide reverse transcriptase inhibitors in real life: a multicentre prospective studyProportion of patients (n) who developed aminotransferase elevations in any determination throughout the follow-up.Back to article page